Luckett
Charles Luckett, Greenbelt, MD US
Patent application number | Description | Published |
---|---|---|
20090311332 | Method for forming mesoporous silica nanoparticles, mesoporous silica nanopartices, and applications thereof - A method for synthesizing a mesoporous silica nanoparticle, a mesoporous silica nanoparticle, and applications thereof are provided. The method includes fractionating a mesoporous silica nanoparticle suspension to produce size-fractionated mesoporous silica nanoparticle. The method further includes etching the size-fractionated mesoporous silica nanoparticle to produce synthesized mesoporous silica nanoparticle having a hollow, porous morphology configured to receive one of a therapeutic agent and an imaging material. The etching includes differential etching of silica from areas of low polymeric density within the mesoporous silica nanoparticle and re-depositing of the silica in areas of higher polymeric density existing near the surface of the mesoporous silica nanoparticle. A target material is loaded into the synthesized mesoporous silica nanoparticle and a controlled released of the target material is provided by decreasing the physiological pH of the surface of the mesoporous silica nanoparticle. | 12-17-2009 |
Christopher Luckett, Louisville, KY US
Patent application number | Description | Published |
---|---|---|
20080249323 | Sorbitol Conversion Process - A process for converting aqueous sorbitol to xylitol and isosorbide in the presence of an acid catalyst, and in the absence of an enzyme or of a hydrogenating catalyst, is disclosed. In the process, a sorbitol solution is reacted with an acid zeolite to produce xylitol and isosorbide. | 10-09-2008 |
Christopher C. Luckett, Louisville, KY US
Patent application number | Description | Published |
---|---|---|
20110319672 | Conversion Of Sugar, Sugar Alcohol, Or Glycerol To Valuable Chemicals Using A Promoted Zirconium Oxide Supported Catalyst - A process for converting a sugar, sugar alcohol, or glycerol to a valuable chemical is described. The process may use a support comprising zirconium oxide promoted by a polyacid or promoter material. A catalytically active metal may be impregnated on the polyacid-promoted zirconium oxide support and the catalyst may then be introduced the sugar, sugar alcohol, or glycerol a source of hydrogen under reaction conditions. At least 40 wt % of the sugar, sugar alcohol or glycerol may be converted to a polyol and/or a shorter carbon-chain alcohol that may include at least one of propylene glycol, ethylene glycol, glycerin, methanol, ethanol, propanol and butandiols. Specific processes for converting glycerin having a selectivity for propylene glycol and for converting sorbitol with a selectivity for propylene glycol, ethylene glycol, and/or glycerin are also described. | 12-29-2011 |
Christopher J. Luckett, Stillwater, OK US
Patent application number | Description | Published |
---|---|---|
20100112878 | Catalyst device for a marine engine which is generally tubular with a rim portion - A catalyst system for a marine engine incorporates a catalyst device within a housing structure. The catalyst device has a rim portion that is disposed within first and second flange surfaces of first and second housing structures. A gasket is provided which is configured to have an opening that allows the rim portion of the catalyst device to be constrained between the first and second flange portions but not between the gasket and either of the first and second flange surfaces. | 05-06-2010 |
Jennifer Luckett, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20100034831 | Agents that Bind a Target in Pulmonary Tissue for Targeting Respiratory Diseases - Disclosed is the use of an agent (e.g., antibody fragment, antagonist, ligand, dAb monomer) that binds a target in pulmonary tissue for the manufacture of a long action or long therapeutic window formulation for local delivery to pulmonary tissue, and methods for administering an agent that binds a target in pulmonary tissue to a subject to produce a long therapeutic window in pulmonary tissue. The formulation is for, and the method comprises, administering locally to pulmonary tissue. Also disclosed is the use of antagonists of TNFR1 for the manufacture of a formulation or medicament for treating, preventing or suppressing lung inflammation or a respiratory disease, and methods of treating such diseases. Also disclosed are the use of agents a for the manufacture of a delivery device (e.g., inhaler, intranasal delivery device) for the treatment or prevention of lung inflammation or a respiratory disease, and a delivery device for the treatment or prevention of lung inflammation or a respiratory disease that contains an agent as described herein. | 02-11-2010 |
20120114651 | METHODS FOR TARGETING PULMONARY DISEASES WITH AGENTS THAT BIND A TARGET IN PULMONARY TISSUE - Disclosed is the use of an agent (e.g., antibody fragment, antagonist, ligand, dAb monomer) that binds a target in pulmonary tissue for the manufacture of a long action or long therapeutic window formulation for local delivery to pulmonary tissue, and methods for administering an agent that binds a target in pulmonary tissue to a subject to produce a long therapeutic window in pulmonary tissue. The formulation is for, and the method comprises, administering locally to pulmonary tissue. Also disclosed is the use of antagonists of TNFR1 for the manufacture of a formulation or medicament for treating, preventing or suppressing lung inflammation or a respiratory disease, and methods of treating such diseases. Also disclosed are the use of agents a for the manufacture of a delivery device (e.g., inhaler, intranasal delivery device) for the treatment or prevention of lung inflammation or a respiratory disease, and a delivery device for the treatment or prevention of lung inflammation or a respiratory disease that contains an agent as described herein. | 05-10-2012 |
20130309227 | METHODS FOR TARGETING PULMONARY DISEASES WITH AGENTS THAT BIND A TARGET IN PULMONARY TISSUE - Disclosed is the use of an agent (e.g., antibody fragment, antagonist, ligand, dAb monomer) that binds a target in pulmonary tissue for the manufacture of a long action or long therapeutic window formulation for local delivery to pulmonary tissue, and methods for administering an agent that binds a target in pulmonary tissue to a subject to produce a long therapeutic window in pulmonary tissue. The formulation is for, and the method comprises, administering locally to pulmonary tissue. Also disclosed is the use of antagonists of TNFR1 for the manufacture of a formulation or medicament for treating, preventing or suppressing lung inflammation or a respiratory disease, and methods of treating such diseases. Also disclosed are the use of agents a for the manufacture of a delivery device (e.g., inhaler, intranasal delivery device) for the treatment or prevention of lung inflammation or a respiratory disease, and a delivery device for the treatment or prevention of lung inflammation or a respiratory disease that contains an agent as described herein. | 11-21-2013 |
Jonathan Luckett, Alexandria, VA US
Patent application number | Description | Published |
---|---|---|
20150127643 | DIGITALLY DISPLAYING AND ORGANIZING PERSONAL MULTIMEDIA CONTENT - An apparatus, system, method, and program product are disclosed for digitally displaying and organizing personal multimedia content. A content module is configured to receive content associated with a user. The content includes one of user-generated content and third-party generated content. The content also includes an associated user rating. A chronological module is configured to present the content on a chronological interface. The chronological interface has an adjustable time period. An organization module is configured to organize the presented content associated with a time period such that content with a higher user rating is more prominently presented than content with a lower user rating. | 05-07-2015 |
Kelly W. Luckett, Florissant, MO US
Patent application number | Description | Published |
---|---|---|
20100050509 | Fabric roof planter - A roof planter comprising growth media capable of sustaining a desired vegetation, a sack retaining a quantity of the growth media, the sack being formed of moisture permeable material that is capable of retaining the growth media, the sack having an opening capable of accepting the growth media, and a pad in association with the sack and capable of separating the sack from the top of a roof. When the desired vegetation is planted in the growth media being retained by the sack, and the pad is positioned between the sack and the roof, the vegetation may grow in the sack on the roof without causing damage to the roof. Further, a fabric roof planter is disclosed having a sack that is fashioned with vertical sidewalls to facilitate a predictable footprint; handles to facilitate horizontal transport; and sealable windows to facilitate the rapid planting of vegetation in the growth media retained by the sack. | 03-04-2010 |
Kelly William Luckett, Florissant, MO US
Patent application number | Description | Published |
---|---|---|
20120117871 | INTERLOCKING PLANTER AND PLANTER SYSTEM - An adaptable terraced planter and system having a plurality of planters, each planter comprising a plastic body configured to retain soil with hinge brackets at each end that when interlocked with a pin or rod form a hinge there between to rotatably connect the planters together, and thereby enable the attachment of said at least one of the plurality of planters to another planter in more than one selective orientation and to allow for the stacking of rows of planters in vertical or tiered rows or variants thereof that conform to a wide variety of topographies. | 05-17-2012 |
Nick G. Luckett, Wombourne GB
Patent application number | Description | Published |
---|---|---|
20100064835 | RACK AND METHOD OF FORMING THE SAME - A method of forming a rack ( | 03-18-2010 |
Thomas J. Luckett, Saline, MI US
Patent application number | Description | Published |
---|---|---|
20100026030 | Upper Glove Box Assembly - An upper glove box for the passenger side of an automotive vehicle in which a door is upwardly hinged and has an upper edge that is received into a void defined in the instrument panel when the door is opened. The revealed wall forward of the opening of the void is an integral portion of the foam injected instrument panel to provide the desired aesthetics. | 02-04-2010 |
Thomas Junior Luckett, Saline, MI US
Patent application number | Description | Published |
---|---|---|
20150258957 | AIR BAG DOOR HINGE FOR A MOTOR VEHICLE - An automobile air bag mounting structure includes a chute defining an opening with a first wall extending from the opening, a cover fully sealing the opening, and a hinge member extending integrally between the first wall and a portion of the cover. The hinge member extends from the first housing wall and to the cover in a direction toward the opening with at least one segment therebetween extending away from the opening. | 09-17-2015 |
William S. Luckett, Richmond, CA US
Patent application number | Description | Published |
---|---|---|
20080248066 | Modified free-living microbes, vaccine compositions and methods of use thereof - Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods of using the modified microbes for the loading, activation, and/or maturation of antigen-presenting cells are also provided. Vaccine compositions comprising the modified microbes and/or the antigen-presenting cells and methods of using the vaccines are also provided. The microbes may be further modified to include heterologous antigens, such as tumor antigens or infectious disease antigens, for use as a vaccine against cancer or infectious diseases. | 10-09-2008 |
20100129406 | HOLIN-ENHANCED VACCINES AND REAGENTS, AND METHODS OF USE THEREOF - The invention provides | 05-27-2010 |